Education
About Us
Working with TipRanks
Follow Us
Intelligent Bio Solutions Inc. (INBS)
:INBS
Total Valuation
Intelligent Bio Solutions has a market cap or net worth of $6.24M. The enterprise value is $8.82M.
Market Cap$6.24M
Enterprise Value$8.82M
Share Statistics
Intelligent Bio Solutions has 9,452,553 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,452,553
Owned by Insiders―
Owned by Institutions5.01%
Financial Efficiency
Intelligent Bio Solutions’s return on equity (ROE) is -3.53 and return on invested capital (ROIC) is -334.68%.
Return on Equity (ROE)-3.53
Return on Assets (ROA)-1.28
Return on Invested Capital (ROIC)-334.68%
Return on Capital Employed (ROCE)-3.67
Revenue Per Employee61.05K
Profits Per Employee-212.10K
Employee Count50
Asset Turnover0.37
Inventory Turnover2.84
Valuation Ratios
The current PE Ratio of Intelligent Bio Solutions is ―. Intelligent Bio Solutions’s PEG ratio is 0.01.
PE Ratio―
PS Ratio2.97
PB Ratio3.03
Price to Fair Value3.03
Price to FCF-0.92
Price to Operating Cash Flow-0.26
PEG Ratio0.01
Income Statement
In the last 12 months, Intelligent Bio Solutions had revenue of 3.05M and earned -10.57M in profits. Earnings per share was -2.00.
Revenue3.05M
Gross Profit1.25M
Operating Income-10.64M
Pretax Income-10.60M
Net Income-10.57M
EBITDA-9.45M
Earnings Per Share (EPS)-2.00
Cash Flow
In the last 12 months, operating cash flow was -10.14M and capital expenditures -302.24K, giving a free cash flow of -10.44M billion.
Operating Cash Flow-10.14M
Free Cash Flow-10.44M
Free Cash Flow per Share-1.10
Dividends & Yields
Intelligent Bio Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.70
52-Week Price Change-60.24%
50-Day Moving Average0.94
200-Day Moving Average1.47
Relative Strength Index (RSI)30.67
Average Volume (3m)358.85K
Important Dates
Intelligent Bio Solutions upcoming earnings date is Feb 6, 2026, Before Open (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateFeb 6, 2026
Ex-Dividend Date―
Financial Position
Intelligent Bio Solutions as a current ratio of 0.77, with Debt / Equity ratio of 9.41%
Current Ratio0.77
Quick Ratio0.65
Debt to Market Cap0.02
Net Debt to EBITDA0.08
Interest Coverage Ratio-174.82
Taxes
In the past 12 months, Intelligent Bio Solutions has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Intelligent Bio Solutions EV to EBITDA ratio is -0.89, with an EV/FCF ratio of -0.84.
EV to Sales2.73
EV to EBITDA-0.89
EV to Free Cash Flow-0.84
EV to Operating Cash Flow-0.86
Balance Sheet
Intelligent Bio Solutions has $1.66M in cash and marketable securities with $1.95M in debt, giving a net cash position of -$291.75K billion.
Cash & Marketable Securities$1.66M
Total Debt$1.95M
Net Cash-$291.75K
Net Cash Per Share-$0.03
Tangible Book Value Per Share-$0.19
Margins
Gross margin is 40.85%, with operating margin of -348.71%, and net profit margin of -346.23%.
Gross Margin40.85%
Operating Margin-348.71%
Pretax Margin-346.23%
Net Profit Margin-346.23%
EBITDA Margin-305.85%
EBIT Margin-345.42%
Analyst Forecast
The average price target for Intelligent Bio Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3.26%
EPS Growth Forecast65.96%